Effect of Acute Exercise on Endothelial Function in Patients With Type 1 Diabetes. (EAEEFD)
Primary Purpose
Type 1 Diabetes Mellitus
Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Resistance exercise session
Aerobic exercise session
Sponsored by
About this trial
This is an interventional prevention trial for Type 1 Diabetes Mellitus focused on measuring Type 1 Diabetes Mellitus, Endothelial progenitor cell, Endothelial function, Exercise
Eligibility Criteria
Inclusion Criteria:
- Type 1 diabetes
- Male gender
- 18-45 years old
Exclusion Criteria:
- Severe autonomic neuropathy
- Diabetic nephropathy established
- Chronic kidney failure
- Limb amputation
- Disabling peripheral arterial disease
- Coronary artery disease
- Heart failure
- Diabetic proliferative retinopathy
- Neoplasms
- Smokers
- Regular physical training
Sites / Locations
- Hospital de Clínicas de Porto AlegreRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Patients with type 1 diabetes
Arm Description
Patients with type 1 diabetes
Outcomes
Primary Outcome Measures
Circulating endothelial progenitor cells
A 20-ml sodium heparin tube will be used and peripheral blood mononuclear cells (PBMC) will be isolated by Ficoll-Hypaque. Blood samples will be diluted with PBS and layered onto Ficoll-Hypaque in 15-ml tubes. Tubes will be centrifuged at 400 g for 30 min and the PBMC at the interface will be collected. Cells will be washed with RPMI 1640 medium and thereafter stained with 5 µl of anti-CD45-FITC , 8 µl of anti-KDR-Alexa Fluor 647, and 5 µl of anti-CD34-PE (all essays from BD, Biosciences, USA). Thereafter, 50 µl of resuspended cells will be incubated (30 min), and subsequently, 500 µl of PBS will be added for acquisition. A FACS Calibur flow cytometer will be used with Quest software (BD Biosciences, USA) equipped with 22 mW argon laser tuned at 488 nm, with a total number counted cells of 200,000 on mononuclear cells gate per sample. Percentage of CD34 positive cells will be calculated based on the number of leukocytes .
Secondary Outcome Measures
Forearm vascular reactivity
Forearm blood flow and reactive hyperemia:
Forearm blood flow will be measured by venous occlusion plethysmography (D.E Hokanson, USA) at the nondominant forearm. A rapid inflator cuff will be used in the upper arm to occlude venous outflow (50-60 mmHg), and three blood flow recordings will be made each minute during 3 minutes. Thereafter, reactive hyperemia will be measure using an occlusion at 250 mmHg for 5 min, which will be released by 10 seconds intervals for 2 minutes. Reactive hyperemia will be calculated using the peak blood flow after the 5 minutes the occlusion.
Full Information
NCT ID
NCT01899872
First Posted
July 8, 2013
Last Updated
July 11, 2013
Sponsor
Hospital de Clinicas de Porto Alegre
1. Study Identification
Unique Protocol Identification Number
NCT01899872
Brief Title
Effect of Acute Exercise on Endothelial Function in Patients With Type 1 Diabetes.
Acronym
EAEEFD
Official Title
Acute Effects of Aerobic and Resistance Exercise on Endothelial Function in Patients With Type 1 Diabetes.
Study Type
Interventional
2. Study Status
Record Verification Date
July 2013
Overall Recruitment Status
Unknown status
Study Start Date
December 2011 (undefined)
Primary Completion Date
November 2013 (Anticipated)
Study Completion Date
December 2013 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital de Clinicas de Porto Alegre
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this study is to evaluate the effect of a single session of aerobic plus resistance exercises on the vascular function of patients with type 1 diabetes mellitus. The investigators hypothesize that a single aerobic exercise session would promote greater benefit in vascular function of patients with type 1 diabetes, as compared with the resistive exercise session.
Detailed Description
The aim of this study is to compare the effect of endurance and resistance exercises on endothelial function in patients with type 1 diabetes mellitus (T1DM). For this purpose, the sample size will consist of 15 patients with DM1, aged between 18 and 45 years, which will undertake the two types of exercises, randomly distributed. Ergospirometry testing will be performed in order to assess possible contraindications to the proposed protocol as well as functional capacity, which will be used in prescription of the endurance exercise session. Similarly, a strength maximal testing will be conducted and used in the prescription of the resistance exercise session.
The endothelial function will be evaluated by vascular reactivity of the forearm and circulating endothelial progenitor cells (EPC) counting. To analyze the vascular reactivity of the forearm, non-invasive venous occlusion plethysmography will be used, whereas flow cytometry method will be used to the analysis of the number of circulating EPC. The endurance exercise session will consist of 40 minutes of cycling on heart rate corresponding to 60% of VO2 max. The resistance exercise session will last 40 minutes, consisting of 4 sets of 12 repetitions at 60% of 1RM, in four exercises for lower limbs. The research will be performed at the Exercise Pathophysiology Research Laboratory of the Hospital de Clinicas de Porto Alegre. The investigators expect to find greater increase in the number of circulating EPC after the endurance exercise session, when compared to the benefits obtained from a session of resistance exercise. Likewise, it is expected to find greater benefits in relation to vascular reactivity of the forearm after a session of endurance exercise when compared to a session of resistance exercise. Considering that most part of the studies that analyze the effects of physical exercise on vascular function does not involve patients with DM1, this project aims to provide a clearer picture of the benefits of different exercises in the acute response of endothelial function in these patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 1 Diabetes Mellitus
Keywords
Type 1 Diabetes Mellitus, Endothelial progenitor cell, Endothelial function, Exercise
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Investigator
Allocation
N/A
Enrollment
15 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Patients with type 1 diabetes
Arm Type
Experimental
Arm Description
Patients with type 1 diabetes
Intervention Type
Behavioral
Intervention Name(s)
Resistance exercise session
Intervention Description
Resistance exercise session consisting of 4 lower-limb exercises, with 4 sets, 12 repetitions per set, at an intensity of 60% of maximal strength.
Intervention Type
Behavioral
Intervention Name(s)
Aerobic exercise session
Intervention Description
Aerobic exercise session consisting of 40 minutes of lower-limb bicycle.
Primary Outcome Measure Information:
Title
Circulating endothelial progenitor cells
Description
A 20-ml sodium heparin tube will be used and peripheral blood mononuclear cells (PBMC) will be isolated by Ficoll-Hypaque. Blood samples will be diluted with PBS and layered onto Ficoll-Hypaque in 15-ml tubes. Tubes will be centrifuged at 400 g for 30 min and the PBMC at the interface will be collected. Cells will be washed with RPMI 1640 medium and thereafter stained with 5 µl of anti-CD45-FITC , 8 µl of anti-KDR-Alexa Fluor 647, and 5 µl of anti-CD34-PE (all essays from BD, Biosciences, USA). Thereafter, 50 µl of resuspended cells will be incubated (30 min), and subsequently, 500 µl of PBS will be added for acquisition. A FACS Calibur flow cytometer will be used with Quest software (BD Biosciences, USA) equipped with 22 mW argon laser tuned at 488 nm, with a total number counted cells of 200,000 on mononuclear cells gate per sample. Percentage of CD34 positive cells will be calculated based on the number of leukocytes .
Time Frame
10 minutes before the exercise session and 10 minutes after the exercise session.
Secondary Outcome Measure Information:
Title
Forearm vascular reactivity
Description
Forearm blood flow and reactive hyperemia:
Forearm blood flow will be measured by venous occlusion plethysmography (D.E Hokanson, USA) at the nondominant forearm. A rapid inflator cuff will be used in the upper arm to occlude venous outflow (50-60 mmHg), and three blood flow recordings will be made each minute during 3 minutes. Thereafter, reactive hyperemia will be measure using an occlusion at 250 mmHg for 5 min, which will be released by 10 seconds intervals for 2 minutes. Reactive hyperemia will be calculated using the peak blood flow after the 5 minutes the occlusion.
Time Frame
10 minutes before the exercise session and 10 minutes after the exercise session.
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Type 1 diabetes
Male gender
18-45 years old
Exclusion Criteria:
Severe autonomic neuropathy
Diabetic nephropathy established
Chronic kidney failure
Limb amputation
Disabling peripheral arterial disease
Coronary artery disease
Heart failure
Diabetic proliferative retinopathy
Neoplasms
Smokers
Regular physical training
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Beatriz D'Agord Schaan, Phd
Phone
51-33598127
Email
beatrizschaan@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Gustavo Waclawovsky, Masters student
Phone
51-33596332
Email
gwsaude@yahoo.com.br
Facility Information:
Facility Name
Hospital de Clínicas de Porto Alegre
City
Porto Alegre
State/Province
Rio Grande do Sul
ZIP/Postal Code
90035903
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gustavo Waclawovsky, Masters
Phone
51-33596332
Email
gwsaude@yahoo.com.br
12. IPD Sharing Statement
Learn more about this trial
Effect of Acute Exercise on Endothelial Function in Patients With Type 1 Diabetes.
We'll reach out to this number within 24 hrs